T-type Ca2+ channel blockers suppress the growth of human cancer cells

Authors
Heo, Jae HoSeo, Han NaChoe, Yun JeongKim, SujinOh, Chun RimKim, Young DeukRhim, HyewhonChoo, Dong JoonKim, JungahnLee, Jae Yeol
Issue Date
2008-07-15
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Citation
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.18, no.14, pp.3899 - 3901
Abstract
In order to further clarify the role of T-type Ca2+ channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca2+ channel blockers. As a result, KYS05090, a most potent T-type Ca2+ channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca2+ channel blocker presents new prospects for cancer treatment. (C) 2008 Elsevier Ltd. All rights reserved.
Keywords
BIOLOGICAL EVALUATION; CALCIUM-CHANNELS; IN-VITRO; INHIBITION; PROLIFERATION; MIBEFRADIL; EXPRESSION; DRUG; BIOLOGICAL EVALUATION; CALCIUM-CHANNELS; IN-VITRO; INHIBITION; PROLIFERATION; MIBEFRADIL; EXPRESSION; DRUG; T-type calcium channel blocker; 3,4-dihydroquinazoline; doxorubicin; anti-cancer
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/133320
DOI
10.1016/j.bmcl.2008.06.034
Appears in Collections:
KIST Article > 2008
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE